1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Afatinib Dimaleate
1.4.3 Dacomitinib
1.4.4 Neratinib
1.4.5 Neucardin
1.4.6 Others
1.5 Market by Application
1.5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Cardiovascular
1.5.4 Central Nervous System
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Receptor Tyrosine Protein Kinase Targeted Drugs Market
1.8.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume
3.3.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume
3.4.1 East Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (2015-2020)
3.5.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (2015-2020)
3.6.1 South Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (2015-2020)
3.8.1 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (2015-2020)
3.9.1 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (2015-2020)
3.10.1 Oceania Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (2015-2020)
3.11.1 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Volume by Application (2015-2020)
15.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Receptor Tyrosine Protein Kinase Targeted Drugs Business
16.1 Aslan Pharmaceuticals Pte Ltd
16.1.1 Aslan Pharmaceuticals Pte Ltd Company Profile
16.1.2 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Puma Biotechnology Inc
16.2.1 Puma Biotechnology Inc Company Profile
16.2.2 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.2.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Hanmi Pharmaceuticals Co Ltd
16.3.1 Hanmi Pharmaceuticals Co Ltd Company Profile
16.3.2 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.3.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Boehringer Ingelheim GmbH
16.4.1 Boehringer Ingelheim GmbH Company Profile
16.4.2 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.4.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Pfizer Inc
16.5.1 Pfizer Inc Company Profile
16.5.2 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.5.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 GamaMabs Pharma SA
16.6.1 GamaMabs Pharma SA Company Profile
16.6.2 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.6.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 XuanZhu Pharma Co Ltd
16.7.1 XuanZhu Pharma Co Ltd Company Profile
16.7.2 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.7.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Minerva Neurosciences Inc
16.8.1 Minerva Neurosciences Inc Company Profile
16.8.2 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.8.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Jiangsu Kanion Pharmaceutical Co Ltd
16.9.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Profile
16.9.2 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.9.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Shanghai Fosun Pharmaceutical (Group) Co Ltd
16.10.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Profile
16.10.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.10.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Zensun (Shanghai) Sci & Tech Co Ltd
16.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Company Profile
16.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Specification
16.11.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Analysis
17.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
17.4 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Receptor Tyrosine Protein Kinase Targeted Drugs Distributors List
18.3 Receptor Tyrosine Protein Kinase Targeted Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Receptor Tyrosine Protein Kinase Targeted Drugs (2021-2026)
20.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase Targeted Drugs (2021-2026)
20.3 Global Forecasted Price of Receptor Tyrosine Protein Kinase Targeted Drugs (2015-2026)
20.4 Global Forecasted Production of Receptor Tyrosine Protein Kinase Targeted Drugs by Region (2021-2026)
20.4.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Country
21.2 East Asia Market Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Country
21.3 Europe Market Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Countriy
21.4 South Asia Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Country
21.6 Middle East Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Country
21.7 Africa Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Country
21.8 Oceania Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Country
21.9 South America Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Country
21.10 Rest of the world Forecasted Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer